Compare NRG Energy Inc (NRG) vs Novavax Inc (NVAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NRG Energy Inc vs Novavax Inc — how do they compare? NRG Energy Inc trades at $107.97 (market cap $22.35B), while Novavax Inc trades at $12.75 (market cap $1.82B). The key difference: NRG Energy Inc is far larger — about 12.3× Novavax Inc's market cap, and NRG Energy Inc pays a 1.79% dividend while Novavax Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold NRG Energy Inc for 63 Days and Novavax Inc for 59 Days on average.
| NRG | NVAX | |
|---|---|---|
Market Cap | $22.35B | $1.82B |
Volume | 5,011,942 | 6,198,505 |
Sector | Utilities | Health |
52-Week High | $184.03 | $12.75 |
52-Week Low | $95.23 | $6.22 |
Typical Hold Time | 63 Days | 59 Days |
Enterprise Value | $46.30B | $1.39B |
Dividend Yield | 1.79% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NRG Energy trades at $106.32, down 2.11% today, amid mixed earnings results with two recent misses but a Q4 2025 beat. The stock shows a bullish technical signal with support at $104 and resistance at $109. Revenue grew to $30.71 billion in 2025, though net income margin compressed to 2.56%. Recent news highlights a 1.2 GW Texas data center project as a growth driver, while analyst consensus remains strongly bullish with a $202.90 price target.
Outlook is positive due to strong analyst support and strategic investments in data center power, but risks include high debt levels and volatile cash flows. The stock offers potential upside from current levels if execution on new projects meets expectations, though earnings consistency and leverage require monitoring.
Novavax (NVAX) trades at $11.01, down 1.87% on the day, with a bullish technical signal from moving averages and a strong buy consensus from analysts (73.9% buy ratings). The company reported a net income of $440.3M in 2025, a significant turnaround from prior losses, though 2026 projections show a return to negative margins. Recent news highlights regulatory approvals for its COVID-19 vaccine and strategic pivots toward its Matrix-M adjuvant platform through partnerships.
The outlook is mixed: near-term catalysts include partnership-driven growth and vaccine approvals, but persistent cash burn and projected 2026 losses pose risks. Investor sentiment is buoyed by recent earnings beats and strategic shifts, yet execution on profitability remains critical for sustained upside.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About NRG Energy Inc
NRG Energy is one of the largest retail energy providers in the U.S., with 7 million customers, including its 2021 acquisition of Direct Energy. It also is one of the largest U.S. independent power producers, with 16 gigawatts of nuclear, coal, gas, and oil power generation capacity primarily in Texas. Since 2018, NRG has divested its 47% stake in NRG Yield, among other renewable energy and conventional generation investments. NRG exited Chapter 11 bankruptcy as a stand-alone entity in December 2003.
Read more on NRG →About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →
